NCT02401815: CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors |
|
|
| Completed | 1b | 51 | US | PLX9486, CGT9486, Pexidartinib, PLX3397, Sunitinib | Cogent Biosciences, Inc., Plexxikon | Gastrointestinal Stromal Tumors | 05/20 | 05/20 | | |
